Tepezza Under Fire

Jessa By Jessa
21 Min Read

Tepezza, a drug developed to treat thyroid eye disease (TED), has recently come under intense scrutiny due to reports of severe side effects. Although the drug was initially celebrated as a breakthrough treatment for the rare autoimmune disorder, patients are now experiencing unintended consequences, such as hearing loss and hearing impairment. Many patients, including those who suffered permanent hearing loss, are filing lawsuits against the manufacturer. These lawsuits claim that the company failed to adequately warn patients of the drug’s potential risks. As the number of adverse events increases, Tepezza litigation is gaining momentum in federal courts across the nation.

Mass Tort America is dedicated to helping those affected by Tepezza side effects. We provide a free consultation to patients who have suffered tepezza hearing loss-related adverse events or other side effects. Our legal team is here to assist you if you or someone you know is dealing with permanent hearing loss, hearing damage, or other symptoms. We can help you understand your legal options and potentially seek compensation for the harm caused by Tepezza treatment.

The Role Of Tepezza In Treating Thyroid Eye Disease

Thyroid eye disease (TED) is a rare autoimmune disorder often linked to hyperthyroidism or Graves’ disease. It causes inflammation and swelling of the muscles and soft tissues around the eyes, leading to symptoms like bulging eyes, double vision, and discomfort. Patients treated with Tepezza initially reported significant improvement in these symptoms. Tepezza is the first and only drug approved by the Food and Drug Administration (FDA) to specifically treat thyroid eye disease.

Despite its initial promise, treatment with Tepezza has now been linked to a variety of serious side effects, including hearing issues like sensorineural hearing loss, muffled hearing, and an ear plugging sensation. The drug’s impact on the auditory system has alarmed many in the medical community, including the Endocrine Society and specialists in clinical endocrinology, who are now raising questions about the drug’s long-term safety. These hearing symptoms have led to concerns about the adequacy of the clinical trials that supported Tepezza’s FDA approval.

Reports indicate that three patients in a clinical trial experienced hearing loss, and this was just the beginning. As more patients began receiving Tepezza infusions, cases of hearing impairment—including permanent hearing impairment—started to surface. Patients now face higher risk of hearing-related adverse events that weren’t previously reported, prompting many to seek legal action.

Hearing Loss: A Devastating Side Effect Of Tepezza

The most alarming side effect associated with Tepezza is hearing loss. Patients receiving Tepezza injections have reported a range of hearing problems, from subjective hearing loss to more severe issues like permanent hearing loss in one or both ears. Some have also experienced a worsening sensorineural hearing loss, where damaged hair cells in the inner ear can no longer transmit sound properly. This type of hearing damage is often irreversible, leaving many patients with lifelong consequences.

New hearing symptoms, such as muffled hearing, the sensation of an ear plugging up, and difficulty hearing their own voice, have been commonly reported. For some patients treated, these hearing problems began shortly after starting treatment with Tepezza, while others noticed hearing-related adverse events months after completing their treatment. The exact cause of these hearing issues is still being studied, but experts believe Tepezza’s mechanism of action may inadvertently affect the auditory system.

As more patients experience hearing impairment, the first Tepezza infusion and hearing loss case is growing in prominence. Individuals who have suffered hearing damage after receiving Tepezza infusions are now filing lawsuits, claiming that Horizon Therapeutics, the manufacturer, failed to provide adequate warnings about the risks. These Tepezza lawsuits seek compensation for the medical costs associated with hearing loss, pain and suffering, and the ongoing impact on patients’ quality of life.

Exploring Additional Tepezza Side Effects

While hearing loss is the most severe side effect reported by patients taking tepezza, it is not the only concern. Patients taking Tepezza have also experienced adverse effects such as muscle spasms, high blood sugar, and gastrointestinal issues like nausea and diarrhea. Infusion reactions, including symptoms like fever and fatigue, have been reported by many individuals receiving Tepezza treatment.

One troubling observation is that patients with preexisting inflammatory bowel disease have reported worsening symptoms after receiving Tepezza infusions. This raises concerns about how Tepezza interacts with other conditions besides inflammatory bowel disease, which may not have been adequately studied in clinical trials. The broader spectrum of side effects adds complexity to the legal cases against Horizon Therapeutics.

These additional side effects further complicate the situation for patients who must now weigh the benefits of Tepezza in treating thyroid eye disease against the potential for serious, life-altering adverse reactions.

Investigating Hearing Damage And Its Long-Term Effects

The mechanism behind Tepezza’s impact on hearing is still under investigation, but experts suspect that the drug’s influence on the IGF-1 receptor may inadvertently damage delicate structures within the ear. This damage can lead to sensorineural hearing loss, a condition that results from damage to the inner ear’s hair cells. Once these cells are damaged, they cannot regenerate, which often leads to permanent hearing impairment.

For patients who experience hearing loss in one or both ears, the consequences can be devastating. Everyday activities like holding conversations, enjoying music, or working in noisy environments become increasingly difficult. Some patients have reported that their own voice sounds muffled or distorted, further complicating their ability to communicate effectively.

As more patients come forward with complaints about hearing problems, the connection between Tepezza and hearing loss is becoming clearer. Horizon Therapeutics is now facing serious legal challenges as patients seek compensation for the permanent hearing damage they suffered as a result of receiving Tepezza treatment.

Tepezza Lawsuits: Holding Horizon Therapeutics Accountable

The growing number of patients who have suffered permanent hearing loss or other adverse effects after receiving Tepezza has led to a surge in lawsuits against Horizon Therapeutics. These Tepezza cases are being consolidated into multi-district litigation (MDL), allowing plaintiffs to share resources while maintaining individual claims. This legal strategy is common in large-scale drug-related lawsuits, where many individuals have been harmed by the same medication.

The central argument in these lawsuits is that Horizon Therapeutics failed to adequately warn patients and healthcare professionals about the risks associated with treatment with Tepezza alone, particularly the risk of permanent hearing loss. Plaintiffs claim that if they had known about the potential for hearing damage, they might have opted for alternative treatments or taken steps to monitor their hearing more closely during therapy.

Tepezza lawyers are now preparing to hear oral arguments in federal courts, with cases filed in districts like the Northern District of Illinois. These lawsuits could result in substantial settlements for affected patients, offering compensation for medical expenses, lost wages, and pain and suffering.

Understanding The FDA’s Role In Tepezza’s Approval

Tepezza received FDA approval in 2020 under a fast-track designation, which allows medications for serious conditions to be brought to market more quickly. While this process helps deliver critical treatments to patients in need, it also raises concerns about the thoroughness of the clinical trials conducted prior to approval.

Tepezza was approved based on clinical trial data showing significant improvement in TED symptoms. However, the long-term safety of the drug, particularly its impact on hearing, was not fully understood at the time of approval. This has led to questions about whether the FDA’s fast-track process adequately protected patients from the drug’s potential risks.

As more reports of hearing-related adverse events emerge, patients and legal experts are calling for increased scrutiny of the fast-track approval process and its role in bringing drugs like Tepezza to market.

Patients’ Experiences With Tepezza Hearing Loss

Patients who have experienced hearing loss after three patients of receiving Tepezza infusions describe a range of hearing symptoms, from mild muffled hearing to complete and permanent hearing impairment. Many patients initially reported hearing loss in one or both ears, which worsened over time. These patients are now faced with the need for hearing aids or other interventions to manage their condition.

For some, the hearing symptoms started during the course of treatment, while others noticed new hearing symptoms months after their final Tepezza infusion. The delay in symptom onset has made it difficult for some patients to connect their hearing problems to the drug, leading to delayed diagnoses and treatment.

Despite these challenges, patients are now coming forward in larger numbers to share their stories and pursue legal action. Their experiences have played a crucial role in bringing attention to the risks of Tepezza and helping to build the case against Horizon Therapeutics.

Patients who have suffered hearing damage or other serious side effects after receiving Tepezza infusions have legal options available to them. Tepezza lawyers are offering free consultations to help individuals understand their rights and determine whether they have a valid case. In many cases, patients may be entitled to compensation for medical bills, lost wages, and the emotional toll of living with permanent hearing impairment.

Class action lawsuits are also being pursued by some patients, allowing them to join a class action lawsuit along forces with others who have experienced similar side effects. These lawsuits aim to hold Horizon Therapeutics accountable for failing to provide adequate warnings about the risks associated with Tepezza treatment.

For those who choose to pursue legal action, the road ahead may be challenging, but it offers the opportunity to seek justice and potentially recover compensation for the harm caused by Tepezza.

Horizon Therapeutics’ Response To Tepezza Lawsuits

As the number of Tepezza lawsuits continues to grow, Horizon Therapeutics has been under increasing pressure to address these legal claims. The company has maintained that the benefits of Tepezza in treating thyroid eye disease outweigh the risks, particularly for patients with severe cases of TED who had few treatment options before the drug’s FDA approval. However, patients and legal experts argue that the company did not provide adequate warnings two patients about the drug’s potential side effects, particularly the risk of hearing loss.

In response to the lawsuits, Horizon Therapeutics has reiterated that all medications carry risks, but they insist that they provided sufficient information about Tepezza’s safety profile. Despite this, the increasing reports of permanent hearing impairment and other adverse events suggest that the drug’s risks may not have been fully understood by patients or healthcare professionals at the time of treatment.

The outcome of the ongoing Tepezza litigation could have significant financial and reputational consequences for Horizon Therapeutics. The company is currently facing both individual lawsuits and multi-district litigation, with plaintiffs arguing that Horizon failed to adequately warn patients and doctors about the potential for hearing damage and other severe side effects.

The Importance Of Early Detection of Hearing Symptoms

For patients undergoing Tepezza treatment, early detection of hearing symptoms is crucial. The onset of hearing loss can sometimes be subtle, with symptoms like muffled hearing, an ear plugging sensation, or difficulty hearing soft sounds being some of the first signs. Recognizing these symptoms early can allow for prompt intervention, which may help mitigate the severity of the hearing impairment.

Patients and healthcare professionals are now being advised to monitor hearing closely during and after treatment with Tepezza. Regular hearing tests and check-ins with a healthcare provider can help catch early signs of hearing damage. This is especially important given that sensorineural hearing loss, once advanced, is often permanent and difficult to treat.

In some cases, stopping Tepezza treatment may help prevent further hearing loss, but this decision must be made in consultation with a healthcare professional. For patients who continue to experience hearing problems, hearing aids or other medical interventions may be necessary to manage the condition.

How Tepezza Differs From Other Treatments For TED

Before Tepezza, the standard treatments for thyroid eye disease primarily involved the use of steroids or surgery to reduce inflammation and manage symptoms like bulging eyes and double vision. Steroids, while effective in some cases, come with their own set of side effects, including increased risk of infections and high blood sugar. Surgical options were invasive and often not entirely effective in restoring normal eye function.

Tepezza offered a less invasive alternative, with clinical trials showing significant improvement in the symptoms of TED. Unlike steroids or surgery, Tepezza works by targeting the IGF-1 receptor, reducing inflammation and swelling in the eye muscles and tissues. This approach allowed for greater symptom relief without the need for invasive procedures.

However, as the side effects of Tepezza have become more apparent, patients and doctors are now weighing the risks and benefits more carefully. While Tepezza remains an important option for treating TED, the growing concerns about hearing loss and other side effects may lead some patients to reconsider more traditional treatment methods.

The Long-Term Impact Of Permanent Hearing Loss

Permanent hearing loss can have a profound impact on a patient’s quality of life, affecting everything from daily communication to professional responsibilities. For many patients who have suffered hearing damage due to Tepezza treatment, the loss is not only physical but also emotional. Difficulty hearing can lead to feelings of isolation, anxiety, and depression, especially for individuals who were unaware of the risks prior to starting treatment.

Hearing impairment can also create challenges in the workplace, especially in professions that require clear communication or auditory perception. Patients who suffer permanent hearing impairment due to Tepezza may find it difficult to perform their job duties, leading to lost wages or the need for career changes. This can create significant financial strain, especially when combined with the costs of ongoing medical care.

Beyond the emotional and financial toll, patients with permanent hearing loss may require assistive devices like hearing aids or cochlear implants to improve their hearing. While these devices can help manage some of the symptoms, they cannot fully restore normal hearing, making it all the more critical for patients to seek compensation for the lasting impact of their condition.

What To Expect From A Tepezza Lawsuit

For patients considering legal action against Horizon Therapeutics, understanding what to expect from a Tepezza lawsuit is important. The first step is often a free consultation with a Tepezza lawyer, who will review your case and determine whether you may be eligible for compensation. During this consultation, your lawyer will gather details about your treatment with Tepezza, the side effects you experienced, and any medical records that document your hearing loss or other adverse effects.

Once your case is filed, it may proceed as part of a class action lawsuit or multi-district litigation. In both cases, your individual experiences will be taken into account, but the litigation process allows plaintiffs to share resources and streamline the legal process. As the lawsuits progress, Tepezza lawyers will present evidence, including expert testimony and medical reports, to show that Horizon Therapeutics failed to provide adequate warnings about the risks of permanent hearing loss.

If the case is successful, plaintiffs may be awarded compensation for their medical bills, lost wages, and pain and suffering. The legal process can take time, but for many patients, pursuing a lawsuit is the best way to hold Horizon Therapeutics accountable and recover the financial resources needed to manage the long-term effects of their hearing impairment.

Why Contact Mass Tort America For Your Tepezza Case?

At Mass Tort America, we understand how overwhelming it can be to face serious medical side effects from a drug that was supposed to help. Our experienced team is dedicated to holding pharmaceutical companies accountable when their products cause harm. We specialize in complex litigation, including cases involving severe side effects like hearing loss, and we may be able to secure compensation for your medical bills, lost wages, and pain and suffering.

Patients from across the United States have turned to us for help in seeking justice against negligent pharmaceutical and drug companies. We offer personalized legal representation, and our Concierge Team is here to guide you through every step of the process. Call us today at 800-356-4338 or visit our contact form at https://masstortamerica.com/contact/ to get started on your case.

TAGGED:
Share This Article